| Xiomara Acevedo Serrano, PHARM D | |
|
Ave.winston Churchill, Esq Parana El Senorial, Rio Piedras, PR 00925 | |
| (787) 751-7219 | |
| (787) 751-7250 |
| Full Name | Xiomara Acevedo Serrano |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | Ave.winston Churchill, Esq Parana El Senorial, Rio Piedras, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174817977 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5296 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Xiomara Acevedo Serrano, PHARM D Ave.winston Churchill, Esq Parana El Senorial, Rio Piedras, PR 00925 Ph: (787) 751-7219 | Xiomara Acevedo Serrano, PHARM D Ave.winston Churchill, Esq Parana El Senorial, Rio Piedras, PR 00925 Ph: (787) 751-7219 |
News Archive
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference.
Researchers have found a genotype that could help identify sickle cell disease (SCD) patients at greatest risk of common, yet severe, complications of SCD.
The American Red Cross and W.W. Grainger, Inc. today welcomed Cisco as the newest participant in the Red Cross "Ready When the Time Comes" corporate volunteer program that trains employees from businesses and mobilizes them as a community-based volunteer force when disasters strike.
A novel investigation into the impacts of neuronal mutations on autism-related characteristics in humans has been described in the open-access journal eLife.
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.
› Verified 4 days ago
Ms. Zulma Linnette Rosario, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1304 Ave Jesus T Pinero, Caparra Terrace, Rio Piedras, PR 00921 Phone: 787-781-0709 | |
Mr. Anibal Navarro, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ave Wiston Churchill Esq Parana El Senorial, Rio Piedras, PR 00925 Phone: 787-751-7250 | |
Yirelia Alejandro Cowan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9410 Ave Los Romeros, Rio Piedras, PR 00926 Phone: 787-720-5155 | |
Dr. Louis Felipe Santiago Leon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Grand Paseo Blvd, Rio Piedras, PR 00926 Phone: 787-283-2555 | |
Miss Coraly Perez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1210 Ave Americo Miranda, Reparto Metropolitano, Rio Piedras, PR 00921 Phone: 787-783-8579 Fax: 787-783-2951 | |
Dr. Mario Yamil Quintero Burgos, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9410 Ave Los Romero Montehiedra Town Center, Rio Piedras, PR 00926 Phone: 787-207-8843 |